期刊文献+

紫杉醇-抗HER2MAb偶联物体外抗肿瘤活性的研究

The research on anti-tumor effect of paclitaxel-HER2 monoclonal antibody conjugate in vitro
下载PDF
导出
摘要 目的研究紫杉醇(Paclitaxel,TAX)与抗HER2(Human epidermal growth factor receptor2,表皮生长因子受体2)单克隆抗体(MAb)偶联物(TAX-抗HER2MAb)体外抗肿瘤作用。方法实验细胞为MCF-7乳癌细胞,MTT法检测细胞增殖抑制作用,进行统计学分析;FCM检测细胞凋亡率;琼脂糖凝胶电泳分析凋亡细胞基因组DNA;Western-blot检测细胞HER2蛋白表达水平。结果在相同药物浓度下偶联物对肿瘤细胞抑制率明显高于TAX,具有统计学意义(P<0.05);半数抑制率药物浓度(IC50)相差20%,具有统计学意义(P<0.05);FCM和琼脂糖凝胶电泳DNA检测分析,偶联物作用的细胞凋亡效果明显高于TAX,Western-blot检测出偶联物作用的肿瘤细胞HER2蛋白表达量明显降低。结论 TAX-抗HER2MAb偶联物体外抗肿瘤作用明显高于TAX。 Objective To investigate the antitumours effect of the Paclitaxel and the HER2(Human epidermal growth factor receptor2)monoclonal antibody conjugates in vitro.Methods using MTT method to detect the depressant effect of MCF-7 cell multiplication and analyze with principle of statistics;using FC method to detect the rate of MCF-7 cell apoptosis;using agarose gel electrophoresis to analyze DNA of MCF-7 cell apoptosis;using Western-blot to detect the expression of the protein of HER2.Results in the same drug level,the depressant effect of the conjugate group was more than the TAX group(P0.05).the IC50 of the conjugate group is 20% lower than the TAX group(P0.05).using FCM and agarose Gel Electrophoresis to analyze cell DNA,the effect of the apoptosis in conjugate groups are apparently better than TAX groups,to compare with other groups,the conjugate groups have lower HER2 protein expression to the tumor cell.Conclusion the antitumours effect of TAX-HER2 monoclonal antibody conjugate group is higher than TAX group in vitro.
出处 《中国实验诊断学》 北大核心 2010年第11期1732-1735,共4页 Chinese Journal of Laboratory Diagnosis
关键词 紫杉醇 表皮生长因子受体2(HER2) 免疫偶联物 Paclitaxel Human epidermal growth factor receptor2 Conjugates
  • 相关文献

参考文献3

二级参考文献57

  • 1冯洁.介绍几种抗肿瘤的靶向新药[J].中国药师,2006,9(2):176-178. 被引量:7
  • 2Micheau O, Solary E, Hammann A et al. Sensitization of cancer cells treated with cytotoxic drugs to Fas-mediated cytotoxicity[J]. J Natl Cancer Inst, 1997, 89:783-9.
  • 3Judson PL,Watson JM,Gehrig PA et al. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy[J]. Cancer Res, 1999, 59(10):2425-32.
  • 4Panvichian R,Orth K, Day ML, et al. Paclitaxel-associated multimininucleation is permitted by the inhibition of caspase activation: a potential early step in drug resistance[J]. Cancer Res, 1998, 58(20):4667-72.
  • 5Nagase Y, Moriyama N, Kurimoto S, et al. Histochemical expression of proliferating cell nuclear antigen (PCNA) for pre and post chemotherapeutic bladder cancer[J]. Nippon Hinyokika Gakkai Zasshi, 1995, 86(5):985-90.
  • 6Haneda H, Katabami M, Miyamoto H.The relationship of the proliferating cell nuclear antigen protein to cis-diamminedichloroplatinum (Ⅱ) resistance of a murine leukemia cell line.P388/CDDP[J]. Oncology, 1991,48(3):234-8.
  • 7Porter AG, Janicke RU. Emerging roles of caspase-3 in apoptosis[J]. Cell Death Differ, 1999, 6(2):99-104.
  • 8Jemal A, Murray T, Samuels A, et al. Cancer stautistics 2003[J]. CA Cancer J Clin, 2003,53(1):5-26.
  • 9Giordano A, Rustum Y M, Wenner C E. Cell cycle;molecular targets for diagnosis and therapy;tumor suppressor genes and cell cycle progression in cancer[J]. J Cell Biochem, 1998,70(1):1-7.
  • 10Colombat P, Sales G, Borusse N, et al. Rituximab(anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden; clinical and molecular evaluation[J]. Blood, 2001,97(1):101-106.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部